Department of Cardiology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark.
Department of Biostatistics University of Copenhagen Denmark.
J Am Heart Assoc. 2020 Feb 18;9(4):e014160. doi: 10.1161/JAHA.119.014160. Epub 2020 Feb 12.
Background Potassium disturbances per se increase the risk of ventricular fibrillation (VF). Whether potassium disturbances in the acute phase of ST-segment-elevation myocardial infarction (STEMI) are associated with VF before primary percutaneous coronary intervention (PPCI) is uncertain. Methods and Results All consecutive STEMI patients were identified in the Eastern Danish Heart Registry from 1999 to 2016. Comorbidities and medication use were assessed from Danish nationwide registries. Potassium levels were collected immediately before PPCI start. Multivariate logistic models were performed to determine the association between potassium and VF. The main analysis included 8624 STEMI patients of whom 822 (9.5%) had VF before PPCI. Compared with 6693 (77.6%) patients with normokalemia (3.5-5.0 mmol/L), 1797 (20.8%) patients with hypokalemia (<3.5 mmol/L) were often women with fewer comorbidities, whereas 134 (1.6%) patients with hyperkalemia (>5.0 mmol/L) were older with more comorbidities. After adjustment, patients with hypokalemia and hyperkalemia had a higher risk of VF before PPCI (odds ratio 1.90, 95% CI 1.57-2.30, <0.001) and (odds ratio 3.36, 95% CI 1.95-5.77, <0.001) compared with normokalemia, respectively. Since the association may reflect a post-resuscitation phenomenon, a sensitivity analysis was performed including 7929 STEMI patients without VF before PPCI of whom 127 (1.6%) had VF during PPCI. Compared with normokalemia, patients with hypokalemia had a significant association with VF during PPCI (odds ratio 1.68, 95% CI 1.01-2.77, =0.045) after adjustment. Conclusions Hypokalemia and hyperkalemia are associated with increased risk of VF before PPCI during STEMI. For hypokalemia, the association may be independent of the measurement of potassium before or after VF.
钾紊乱本身会增加心室颤动(VF)的风险。急性 ST 段抬高型心肌梗死(STEMI)期间的钾紊乱是否与直接经皮冠状动脉介入治疗(PPCI)前的 VF 有关尚不确定。
本研究纳入了 1999 年至 2016 年期间丹麦东部心脏注册研究中的所有连续 STEMI 患者。共病和药物使用情况来自丹麦全国登记处评估。在进行 PPCI 前即刻采集血钾水平。采用多变量逻辑模型来确定钾与 VF 之间的关系。主要分析纳入了 8624 例 STEMI 患者,其中 822 例(9.5%)在 PPCI 前发生 VF。与 6693 例(77.6%)血钾正常(3.5-5.0mmol/L)患者相比,1797 例(20.8%)低血钾症(<3.5mmol/L)患者多为女性且共病较少,而 134 例(1.6%)高血钾症(>5.0mmol/L)患者多为老年且共病较多。校正后,低钾血症和高钾血症患者在 PPCI 前发生 VF 的风险更高(比值比 1.90,95%CI 1.57-2.30,<0.001)和(比值比 3.36,95%CI 1.95-5.77,<0.001)与血钾正常相比。由于这种关联可能反映了复苏后的现象,因此进行了敏感性分析,纳入了 7929 例在 PPCI 前没有 VF 的 STEMI 患者,其中 127 例(1.6%)在 PPCI 期间发生了 VF。校正后,与血钾正常相比,低钾血症患者在 PPCI 期间发生 VF 的风险显著增加(比值比 1.68,95%CI 1.01-2.77,=0.045)。
低钾血症和高钾血症与 STEMI 期间 PPCI 前 VF 的风险增加相关。对于低钾血症,这种关联可能独立于 VF 前后的血钾测量值。